Chih-Ming Su

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 2

Top Topics

Signaling Pathway

Bone Regeneration

Breast Cancer Cells

Top Venues

Disease markers

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chia-Hung Hsu, Hon-Ping Ma, Jiann Ruey Ong, Ming-Shou Hsieh, Vijesh Kumar Yadav, Chi-Tai Yeh, Tsu-Yi Chao, Wei-Hwa Lee, Wen-Chien Huang, Kuang-Tai Kuo, Iat-Hang Fong, Chih-Cheng Lin, Chih-Ming Su
Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression. Disease markers 2022 (2022)
Jiefeng Zhou, Chih-Ming Su, Hsin-An Chen, Shicong Du, Chang-Wei Li, Haoran Wu, Shin-Han Tsai, Yu-Ting Yeh
Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer. OncoTargets and therapy 13 (2020)
Hsin-An Chen, Chih-Ming Su, Hsiao-Yen Hsieh, Chun-Liang Tung, Cheng-Da Hsu, Yuan-Hung Wang, Cheng-Huang Shen
Clinical significance of survivin expression in patients with urothelial carcinoma. Disease markers 2014 (2014)